Adagene, Inc. Sponsored ADRAdagene, Inc. Sponsored ADRAdagene, Inc. Sponsored ADR

Adagene, Inc. Sponsored ADR

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪86.26 M‬EUR
−0.55EUR
‪−32.29 M‬EUR
‪99.69 K‬EUR
‪36.74 M‬
Beta (1Y)
0.53

About Adagene, Inc. Sponsored ADR


CEO
Pei Zhi Luo
Headquarters
Suzhou
Founded
2011
ISIN
US0053291078
FIGI
BBG011PS2QT6
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Check out other big names from the same industry as 978.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.